drugset / Trial / NCT03065530

Intravenous Dexmedetomidine for Cesarean Section

NCT03065530

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Nervous, anxiety, fear and other psychological reactions always appears in parturients during cesarean section. This study intends to investigate the effectiveness and safety of dexmedetomidine combined with butorphanol tartrate for postoperative analgesia and breastfeeding after caesarean section.

Timeline

Start
2017-02-07
Primary completion
2017-09-30
Completion
2017-10-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.03 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.05 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.08 ug/kg Intravenous
Comparator Butorphanol Other / unclassified 3 ug/kg

Indications

No indication recorded.